Search Results

This Network Watch presents street names that appeared in DAWN data for the first time during the first quarter of 2025, identifies common slang terms reported at ED visits by hospital regions, and highlights emerging challenges.

This report presents data from DAWN using national estimates and trends of opioid-involved emergency department (ED) visits in the United States, including those involving prescription opioids, fentanyl, heroin, and opioids not otherwise specified.

Monitoring the distribution and impact of opioid overdose reversal medications such as naloxone is essential to optimizing overdose prevention strategies and improving public health outcomes. This Statistical Data Profile, the first to use performance data from two SAMHSA grant programs, examines the distribution of FDA-approved opioid overdose reversal medications, including...

This spotlight highlights a notable finding from the evaluation of SAMHSA’s Projects for Assistance in Transition from Homelessness (PATH) program published in 2024. The PATH program is intended to reduce homelessness among persons experiencing severe mental illness or co-occurring mental illness and substance use disorders. PATH collects data on the...

Find data on the nonuse of substances among adolescents aged 12 to 17 from the 2023 National Survey on Drug Use and Health (NSDUH). Estimates include illicit drugs, alcohol, tobacco products, and nicotine vaping.

Use this guide to analyze the National Survey on Drug Use and Health (NSDUH) for yourself. This guide provides data users with information and guidance to properly analyze the NSDUH public use files, including descriptions of the survey scope and design; guidelines for navigating the codebook and other methodological resources...

Find state-level estimates for 38 measures of substance use and mental health from the 2022-2023 National Surveys on Drug Use and Health (NSDUH). These estimates are based on small area estimation (SAE) methods in which state-level NSDUH data are combined with other data from smaller geographies. The combined data are...

Compare state and regional estimates for measures of substance use and mental health using p-values. The tables are a companion to the state-level estimate tables from the 2022-2023 National Surveys on Drug Use and Health (NSDUH). This resource includes both the p-value tables and a guide for their use in...

Browse state-level percentage estimates based on the 2022-2023 National Surveys on Drug Use and Health (NSDUH). The 41 tables include estimates for measures of both substance use and mental health, by age group, along with 95% confidence intervals. The percentages are based on small area estimation (SAE) methods, in which...

Browse state-level estimates in thousands based on the 2022-2023 National Surveys on Drug Use and Health (NSDUH). The 41 tables include estimates for measures of both substance use and mental health, by age group, along with 95% confidence intervals. The estimates are based on small area estimation (SAE) methods, in...

Compare state-level National Survey on Drug Use and Health (NSDUH) estimates with those from the Behavioral Risk Factor Surveillance System (BRFSS) from the Centers for Disease Control and Prevention. Comparisons are available for alcohol and cigarette use among people ages 18 or older.

Browse population estimates based on the 2022-2023 National Surveys on Drug Use and Health (NSDUH) for each state and region. There are four tables for each geographic area, which present population estimates and percentages for 38 measures of substance use and mental health by age group. These estimates are based...

Examine the change in state estimates between 2021-2022 and 2022-2023 from the National Surveys on Drug Use and Health (NSDUH) and determine if they were statistically significant using p-values. The tables accompany the 2022-2023 NSDUH State Estimates of Substance Use and Mental Health, and include estimates for both time...

Use this guide to help interpret the 2022-2023 state-level estimates from the National Surveys on Drug Use and Health (NSDUH). It includes a summary of NSDUH and the small area estimation (SAE) methodology, as well as sample sizes, response rates, and total population estimates for the associated tables.

This report presents data on national estimates of substance-related ED visits from 53 participating DAWN hospitals in 2023. The data includes (1) all drug-related ED visits, (2) the top substances involved in drug-related ED visits, (3) opioid-related ED visits by type, and (4) polysubstance-related ED visits.